Frequently Asked Questions
The global Cardiac output monitoring devices market was valued at USD 1.3 Billion in 2022.
The Cardiac output monitoring devices market is expected to grow at a CAGR of 4.10% between 2023 and 2030, reaching USD 1.722258984 Billion in 2030.
Pulmonary Artery Catheter is the leading segment by technology, holding around more than three-firth of the share in value in 2022.
Hospitals govern the demand for Cardiac output monitoring devices worldwide, holding a massive share of nearly 30% in 2022.
Lithium dilution technique segments are expected to post the highest CAGR during the forecast period.
North America is fueling the growth of the Cardiac output monitoring devices industry, with nearly a two-thirds share in 2022.
The top players include GE Healthcare, Getinge AB, Edward Lifesciences Corporation, Inc., LiDCO Group plc, ICU Medical, Inc., Baxter International, Deltex Medical Group, and others.
Rising prevalence of cardiovascular diseases and the growing aging population & the rising adoption of minimally invasive surgeries, and the emphasis on early detection and prevention of cardiac disorders are the major market drivers.
Huge cost associated with devices that limit accessibility, particularly in developing regions with limited healthcare budgets & regulatory hurdles, and the need for extensive clinical validation are still restraints of the Cardiac output monitoring devices industry.
Increasing focus on patient-centric healthcare and personalized medicine & emergence of artificial intelligence and machine learning technologies opens avenues for enhanced data analysis and predictive modeling, facilitating early detection of cardiac abnormalities are opportunities for the Cardiac output monitoring devices industry.